As we crossed into the latter half of the 2020s, the financial landscape of the United States underwent a whirlwind of change, the likes of which hadn’t been seen in quite some time. With the re-election of Donald Trump, a new era dawned on both the domestic and international fronts, bringing with it swift alterations in policymaking and a series of fluctuating tariffs. These maneuvers have stoked the fires of speculation among economic pundits, many of whom have harbored concerns about the nation teetering on the edge of a recession.
Despite the initial shockwaves felt in the early stages of April 2025, leading to a notable nosedive in market values, the narrative began to shift as the year progressed. By the time the second quarter was wrapping up, the scenery was markedly different. The stock market, epitomized by its benchmark indices, staged an admirable recovery, ascending over 6% in the period in question and entering the third quarter on an unprecedented high note.
However, it’s critical to underscore that this resurgence has not been uniform across the board. A handful of prominent companies have lagged behind in this bullish revival, struggling to match the momentum of the broader market. Yet, within this subset of underperformers lies a silver lining — an opportunity for astute investors to capitalise on potential turnarounds, which could yield considerable gains.
UnitedHealth Group Inc – A Titan Under Pressure
Among the notable names grappling with adversity is UnitedHealth Group Inc., a behemoth in the health insurance and services domain. The onset of 2025 was harsh for UnitedHealth, marked by disappointing earnings reports and a stock price that endured a dramatic slump, eroding over 40% of its value by May. Still reigning as the premier insurer in the United States by market capitalisation, the company has found itself in a fraught position.
The challenges facing UnitedHealth are multifaceted. Rising medical costs have significantly pressured its earnings outlook, a high-profile CEO departure has jolted its leadership stability, and an ongoing fraud investigation has tarnished its public image. Despite these hurdles, some analysts remain cautiously optimistic about the firm’s prospects. They highlight the recent dividend hike and divestiture of a portion of its Latin American operations, Banmedica, as moves that could bolster shareholder value. Given the durable nature of its business model, combining healthcare services with insurance, UnitedHealth could be poised for a rebound, offering investors a potentially lucrative entry point.
Edison International – A Utility in the Eye of the Storm
Another entity caught in tumultuous waters is Edison International, a stalwart in Southern California’s utility sector. The company’s narrative in the first half of 2025 was one of volatility, with its stock buffeted by the dual forces of rampant wildfires across the region and the looming shadow of legislative overhaul. Entering the third quarter, Edison’s shares had plummeted by more than 22%.
The potential enactment of SB 254 looms large over Edison, proposing stringent price controls and imposing additional financial burdens for fire mitigation efforts. This legislative backdrop injects a sizeable dose of uncertainty, predominantly impacting the company’s short-term performance outlook. Nevertheless, a cadre of analysts maintains a bullish stance, forecasting an earnings uptick in the near horizon and citing the firm’s robust dividend yield as a draw for investors. Those willing to navigate through regulatory ambiguity may find Edison an enticing proposition, especially at its current valuation levels.
Salesforce – Finding Footing Amidst the Flux
Salesforce Inc., a leader in the customer relationship management (CRM) software arena, presents yet another narrative of a tumultuous first half followed by budding optimism. The tech giant saw its stock price wane, slipping by 14% during the initial six months of 2025. Despite this setback, Salesforce has shown signs of strategic recalibration, pivoting towards a model that favours profitability and enhanced margins.
The introduction of innovative offerings, such as the agentic AI platform Agentforce, alongside robust performance in its core products and impressive year-over-year revenue growth in its data cloud and AI segments, underlines Salesforce’s resilience. Coupled with an improved earnings outlook and a commitment to shareholder returns through dividends and share repurchases, Salesforce is steadily carving a path to recovery. For investors seeking growth amidst the shifting sands of the tech landscape, Salesforce could represent a compelling opportunity.
In sum, the first half of 2025 has been anything but predictable for U.S. securities, marked by swift policy shifts and economic uncertainties. Yet, within the turmoil, certain firms stand out as potential beacons for savvy investors. UnitedHealth, Edison International, and Salesforce, each facing their unique challenges, also embody the possibility of significant upside. As we advance deeper into the decade, these stories of potential turnarounds underscore the complex, yet rewarding nature of investing in a world in perpetual motion.
